K51.0 K51
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Age = 18 years - Diagnostic of ulcerative colitis (histologically confirmed or by a coloscopy) = 2 years - Ulcerative colitis in remission phase or with a low or moderate disease activity. - Regular intake of a mesalazine preparation in a dose of 1,2 - 4,8 g/d - Availability of a written agreement to participate in the study.
Exclusion criteria
Exclusion criteria: - Acute ulcerative colitis - Mesalazine intolerance - Colektomy - Ileostoma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference between study arms by baseline and one year after executed advanced training in the Morisky Medication Adherence Scale regarding the medication intake. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Examination of the life quality obtained by IBDQ-D by baseline and one year after performed advanced training. - Examination of the course of the disease obtained by CAI by baseline and one year after performed advanced training. - Examination of the White-Coat-Compliance based on the proven 5-ASA urin measurement by baseline and one year after performed advanced training. | — |
Countries
Germany
Contacts
Kompetenznetz Darmerkrankungen